Breast Cancer and ESMO 2021

The Breast Cancer Channel on VJOncology is supported by Gilead. These supporters have no influence over the production of the content.

2:06
NGS multi-panel gene testing for newly diagnosed patients with metastatic breast cancer
Evandro de Azambuja • 18 Sep 2021
4:40
AMEERA-1 updates: amcenestrant plus palbociclib for patients with ER+/HER2– advanced breast cancer
Mario Campone • 30 Sep 2021
2:46
Prognostic impact of immune interactions in patients with HER2+ and TNBC with brain metastases
Gaia Griguolo • 21 Sep 2021
2:38
HER2+ and TNBC highlights from ESMO 2021
Gaia Griguolo • 21 Sep 2021
1:55
Advances in treatments for HER2-positive metastatic breast cancer
Cristina Saura Manich • 29 Sep 2021
1:04
Highlights in breast cancer from ESMO 2021
Cristina Saura Manich • 29 Sep 2021
1:36
ctDNA assay for detection of recurrent disease in patients with early-stage breast cancer
Wolfgang Janni • 22 Sep 2021
1:52
Role of RT in early breast cancer
Icro Meattini • 8 Sep 2021
2:34
ESMO 2021 breast cancer highlights: TULIP and KEYNOTE-355
Javier Cortés • 24 Sep 2021
1:19
MONALEESA-2: improved OS seen in HR+ advanced breast cancer treated with ribociclib + letrozole
Wolfgang Janni • 22 Sep 2021
0:48
Highlights from ESMO: DESTINY-Breast03
Elena Garralda • 29 Sep 2021
1:24
Treatments for estrogen-positive breast cancer
Yeon Hee Park • 23 Sep 2021
5:37
Therapeutic landscape for patients with HER2-positive breast cancer with active brain metastases
Rupert Bartsch • 29 Sep 2021
2:15
Neo-PATH: TAHP for patients with HER2-positive breast cancer
Yeon Hee Park • 23 Sep 2021
2:15
Treatment strategies for HER2+ metastatic breast cancer
Rupert Bartsch • 29 Sep 2021
7:27
POLARIS: palbociclib for BIPOC patients with HER2-negative breast cancer
Gabrielle Rocque • 20 Sep 2021

The Breast Cancer Channel on VJOncology is supported by Gilead.

These supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Breast Cancer Channel, please contact us.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals